Autor: "Liang, Jin-e" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Kang-ai Injection (康艾注射液) Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway
Autorzy :: Zheng, Chun-leiAff1, Aff2, Aff3
Hou, Ke-zuoAff1, Aff2, Aff3
Wang, An-qiAff1, Aff2, Aff3
Fang, Wan-xiaAff1, Aff2, Aff3
Yu, Shi-tongAff1, Aff2, Aff3
Liang, Jin-eAff1, Aff2, Aff3
Qi, Hai-yanAff1, Aff2, Aff3
Qu, Xiu-juanAff1, Aff2, Aff3
Liu, Yun-pengAff1, Aff2, Aff3
Che, Xiao-fangAff1, Aff2, Aff3; Pokaż więcej
Źródło :: Chinese Journal of Integrative Medicine. :1-7
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Informacja :: Dostęp do tej pozycji wymaga zalogowania się.
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Informacja :: Dostęp do tej pozycji wymaga zalogowania się.
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Informacja :: Dostęp do tej pozycji wymaga zalogowania się.
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Kang-ai Injection () Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 Pathway.
Autorzy :: Zheng CL; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China.; Liaoning Province Clinical Research Center for Cancer, Shenyang, 110001, China.
Hou KZ; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China.; Liaoning Province Clinical Research Center for Cancer, Shenyang, 110001, China.
Wang AQ; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China.; Liaoning Province Clinical Research Center for Cancer, Shenyang, 110001, China.
Fang WX; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China.; Liaoning Province Clinical Research Center for Cancer, Shenyang, 110001, China.
Yu ST; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China.; Liaoning Province Clinical Research Center for Cancer, Shenyang, 110001, China.
Liang JE; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China.; Liaoning Province Clinical Research Center for Cancer, Shenyang, 110001, China.
Qi HY; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China.; Liaoning Province Clinical Research Center for Cancer, Shenyang, 110001, China.
Qu XJ; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China.; Liaoning Province Clinical Research Center for Cancer, Shenyang, 110001, China.
Liu YP; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China.; Liaoning Province Clinical Research Center for Cancer, Shenyang, 110001, China.
Che XF; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, 110001, China. .; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, 110001, China. .; Liaoning Province Clinical Research Center for Cancer, Shenyang, 110001, China. .; Pokaż więcej
Źródło :: Chinese journal of integrative medicine [Chin J Integr Med] 2020 Jul 09. Date of Electronic Publication: 2020 Jul 09.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Liang, Jin-e"" wg kryterium: Autor

Aktywne filtry:

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu